Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
U.S. markets open in 31 minutes
S&P Futures
5,061.75 +14.25 (+0.28%) Dow Futures
38,554.00 +86.00 (+0.22%) Nasdaq Futures
17,402.75 +52.75 (+0.30%) Russell 2000 Futures
1,978.40 -4.20 (-0.21%) Crude Oil
80.98 -0.92 (-1.12%) Gold
2,323.40 -23.00 (-0.98%)
At close: 04:00PM EDT
Pre-Market:
Mountain
Settings
- Reuters
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.
- Insider Monkey
25 Richest Billionaires in Healthcare Industry
In this article, we discuss the 25 richest billionaires in healthcare industry. To skip the detailed analysis of the healthcare industry, go directly to the 5 Richest Billionaires in Healthcare Industry. Global Healthcare Industry Outlook and Trends The global healthcare industry is going through a massive transition amid technological advancements, changing patient needs, and demographic […]
- GlobeNewswire
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (2:00 p.m. CEST) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this
Advertisement
Advertisement
Advertisement